Hologic’s Acessa procedure is now covered by Anthem Blue Cross Blue Shield, the second largest health plan in the United States. Anthem has updated its medical policy to cover Radiofrequency Ablation (LAP-RFA), which includes the Acessa procedure for women suffering from uterine fibroids. The updated policy creates access to uterine-preserving care for Anthem’s approximately 40 million members in all 50 states, providing…
LiNA Medical USA and FEMSelect have announced the U.S. launch of FEMSelect’s EnPlace pelvic floor ligament fixation system. The EnPlace patented delivery system enables the precise guidance, insertion and deployment of a small, nitinol anchor for pelvic floor ligament fixation. The approach is performed with minimal dissection and no mesh. This nationwide launch will now enable access to the technology across the US for both pelvic…
Leading UK-based femtech company Elvie has just announced the closing of a £58M Series C. The round was led by BFG with participation from funds and accounts managed by BlackRock, a consortium including Hiro Capital and Westerly Winds, Octopus Ventures and PPGL. Elvie was founded in 2013 by Tania Boler. Its current product line-up includes Elvie Trainer, an app-connected Kegel trainer, Elvie…
Pelvital, a privately held medical device company that has developed Flyte, a clinically proven, FDA-cleared, non-surgical treatment for female stress urinary incontinence (SUI), announced today that Ryan Willemsen has been appointed Chief Operations Officer. In this role, Willemsen will be responsible for leading the operations of Pelvital with a focus on market adoption of Flyte, building a global sales and distribution capability,…
Women’s health startup Stix now offers a comprehensive suite of products for yeast infections. According to the company 75% of women will have at least one yeast infection in their lifetime. Stix was founded in 2019 and started out selling pregnancy and ovulation tests. Co-founders Cynthia Plotch and Jamie Norwood met through the Venture for America fellowship. After spending nights and weekends researching…
Pharmavite, the makers of Nature Made vitamins and supplements, announced today that it has acquired leading urinary health brand Uqora as part of its ongoing commitment to providing science-based solutions in the underserved women’s health market. Founded in 2017 by partners Jenna Ryan and Spencer Gordon, Uqora is a San Diego-based company addressing urinary health issues with a combination of reactive solutions and proactive care. Uqora…
Lupin Pharmaceuticals, a U.S. based wholly-owned subsidiary of global pharma major Lupin Limited (Lupin), announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental New Drug Application to expand the use of SOLOSEC (secnidazole) to include the treatment of trichomoniasis in adults. Trichomoniasis vaginalis is the most common non-viral, curable sexually transmitted infection (STI) in the U.S., affecting an estimated…
Elidah, with the first non-intrusive device to treat incontinence at home, announced that its ELITONE device is now covered by Medicare. Women dealing with bladder leaks can treat their leaks rather than simply covering them up with pads or diapers. Urinary incontinence symptoms often start after childbirth, but the symptoms usually progress and become more bothersome as women age. Medicare is the…
